Palomar Holdings, Inc. Appoints Thomas Bradley to its Board of Directors
LA JOLLA, Calif., March 01, 2024 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ: PLMR) (the “Company”) today announced that Thomas […]
Workhorse Group Sets Fourth Quarter and Full Year 2023 Earnings Call for Tuesday, March 12, 2024 at 12:00 p.m. ET
CINCINNATI, March 01, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company […]
Dyadic to Attend Industry Events in March
JUPITER, Fla. , March 01, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global […]
Empowering the Future of Healthcare: How Healthcare Triangle’s AI Initiative Sets a New Standard in Patient Care Excellence
PLEASANTON, Calif., March 01, 2024 (GLOBE NEWSWIRE) — Healthcare Triangle Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” HCTI” or the “Company”), embarks […]
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and […]
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical […]
Comscore and TEGNA Sign Multi-Year Agreement for Local Linear and Cross-Platform Audience Measurement
RESTON, Va., March 01, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (NASDAQ: SCOR) and TEGNA Inc. (NYSE: TGNA) today announced they […]
Fate Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO, March 01, 2024 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage […]
Aemetis to Review Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
CUPERTINO, CA, March 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused […]
